Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Horizons in radionuclide therapy: 1985 update.

W H Beierwaltes

    Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
    |April 1, 1985
    PubMed
    Summary

    Radiopharmaceuticals offer a promising alternative to conventional cancer treatments like radiation and chemotherapy. New data on [131I]MIBG in various cancers supports this approach for solid tumors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Remissions in thyrotoxicosis after discontinuing thiouracil.

    Journal of the American Medical Association·2010
    Same author

    Liver biopsy; clinical evaluation of a trephine needle.

    University Hospital bulletin·2010
    Same author

    Pulmonary arteriovenous aneurysm with secondary polycythemia; report of the first case treated by lobectomy.

    Journal of the American Medical Association·2010
    Same author

    Complications following the administration of thiouracil.

    The American journal of the medical sciences·2010
    Same author

    Liver biopsy; clinical experience with a trephine needle.

    Proceedings. American Federation for Clinical Research·2010
    Same author

    Thiouracil and propylthiouracil; a comparative clinical study.

    The Journal of laboratory and clinical medicine·2010

    Area of Science:

    • Nuclear medicine
    • Oncology
    • Radiopharmaceutical therapy

    Background:

    • Conventional radiation and chemotherapy have limitations in treating solid tumors.
    • Radiopharmaceuticals offer targeted internal radiation delivery.
    • Early research suggested the potential of radiopharmaceuticals to surpass conventional methods.

    Purpose of the Study:

    • To update and support the 1981 statement on radiopharmaceutical therapy.
    • To present new data on the efficacy of [131I]MIBG in various cancers.
    • To propose a plan for applying radionuclide therapy to most solid tumors.

    Main Methods:

    • Review of existing data and new findings.
    • Focus on the application of Iodine-131 meta-iodobenzylguanidine ([131I]MIBG).
    • Development of a strategic plan for broader implementation.

    Main Results:

    • New data reinforces the potential of internally administered radiopharmaceuticals.
    • [131I]MIBG demonstrates efficacy in treating several types of cancer.
    • A framework for applying non-sealed source radionuclide therapy to solid tumors is proposed.

    Conclusions:

    • Radiopharmaceutical therapy is a viable and advancing alternative to conventional treatments.
    • Further research and application of agents like [131I]MIBG are warranted.
    • Non-sealed source radionuclide therapy holds significant promise for a wide range of solid tumors.

    Related Experiment Videos